Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702
Status:
Completed
Trial end date:
2009-12-24
Target enrollment:
Participant gender:
Summary
GSK1034702 is being developed for improving cognitive impairment in diseases such as
Alzheimer's disease and schizophrenia. This study will be done in healthy men and women of no
child beading potential to investigate repeated doses of the study medicine. The study will
investigate the following questions, do repeated doses of the study medicine have any
important side effects when taken by mouth? How much of the study medicine gets into the
bloodstream, and how quickly does the body get rid of it? Does the study medicine affect
memory, attention and problem-solving skills? What are the effects when the study medicine
and dextromethorphan are taken together.